Sunday , September 26 2021

Cipla expects surge in demand for respiratory drugs, inhalers in winter

The firm enjoys a massive 68.7 per cent market share in the respiratory inhalation segment in India and has started working on aligning supplies so that there is no shortage of these critical medicineThe firm enjoys a massive 68.7 per cent market share in the respiratory inhalation segment in India and has started working on aligning supplies so that there is no shortage of these critical medicineRead MoreCompanies

About

Check Also

Social impact venture Charitnation helps more than 25000 families of migrant and daily wage earners during Covid-19 crisis in India

New Delhi [India], September 15 (ANI/SRV Media): India was put in lockdown to halt the …

Leave a Reply

Your email address will not be published. Required fields are marked *